A Clinical Trial to Evaluate the Effects of Glow Shakes Premium Collagen Meal Replacement on Body Composition, Weight Management, Skin, Hair, Nail, Gut, and Overall Health Outcomes
This is a single-group, open-label, decentralized clinical trial evaluating the effects of 6 weeks of daily Glow Shakes Premium Collagen Meal Replacement consumption on body composition, weight management, and self-reported health outcomes in 40 adults aged 18-55 years with a BMI between 25-35 kg/m².
All participants will consume Glow Shakes Premium Collagen Meal Replacement twice daily, replacing two typical meals, for 6 consecutive weeks. Assessments will be conducted at Baseline, Week 2, Week 4, and Week 6 and will include validated self-report questionnaires and body composition measurements via the Withings smart scale. All study activities are conducted remotely; products are shipped directly to participants' homes and all data are submitted digitally through the Citruslabs study platform.
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Izaak Woodley
- Email: izaakwoodley@thecollagen.co
Study Locations
-
-
Nevada
-
Las Vegas, Nevada, United States, 89101
- Citruslabs
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Adults aged 18-55 years at the time of enrollment.
- BMI between 25-35 kg/m² at screening, as confirmed via participant self-report and/or Withings smart scale measurement at Baseline.
- Self-reported goals around weight management, body composition improvement, or overall health and wellness at the time of enrollment.
- Willing and able to use Glow Shakes Premium Collagen Meal Replacement as a daily meal replacement (replacing two typical meals) for 6 consecutive weeks and to complete all questionnaire assessments and Withings smart scale body composition measurements at Baseline, Week 2, Week 4, and Week 6.
- Willing to maintain current diet (except for the test product), exercise routine, and lifestyle habits for the duration of the 6-week study, without introducing any new supplements or products specifically targeting weight loss, appetite, or body composition.
- In good general health.
- Resides in the United States.
Exclusion Criteria:
- Pregnant or breastfeeding at the time of enrollment, or planning to become pregnant during the 6-week study period.
- Currently using GLP-1 receptor agonists, dual-incretin medications, prescription weight loss drugs, or any other prescription medication directly affecting appetite or body weight.
- Known allergy or intolerance to any ingredient in the Glow Shakes formulation, including milk protein, whey protein, or collagen-derived (bovine) ingredients.
- Diagnosed with a serious medical condition requiring medical nutritional management, including but not limited to Type 1 diabetes, active cancer, or severe renal or hepatic disease.
- Currently testing, or plan to in the next 6 weeks, a product for another research study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Glow Shakes Premium Collagen Meal Replacement Arm
|
All participants will consume Glow Shakes Premium Collagen Meal Replacement twice daily (replacing two meals) for 6 weeks. Assessments will be conducted at four timepoints: Baseline, Week 2, Week 4, and Week 6. Assessments will include validated self-report questionnaires and body composition measurements via the Withings smart scale. |
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Body Weight
Time Frame: Baseline to Week 6
|
Change in body weight (kg) from Baseline to Week 6 as measured by the Withings smart scale (participant self-administered at home) |
Baseline to Week 6
|
|
Change in Body Fat Percentage
Time Frame: Baseline to Week 6
|
Change in body fat percentage (%) from Baseline to Week 6 as measured by the Withings smart scale (participant self-administered at home) |
Baseline to Week 6
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Self-Reported Weight Management Score
Time Frame: Baseline, Week 2, Week 4, and Week 6
|
Change from Baseline in self-reported weight management scores as assessed via self-report questionnaire |
Baseline, Week 2, Week 4, and Week 6
|
|
Change in Self-Reported Hunger Intensity
Time Frame: Baseline, Week 2, Week 4, and Week 6
|
Change from Baseline in self-reported hunger intensity as assessed via self-report questionnaire |
Baseline, Week 2, Week 4, and Week 6
|
|
Change in Self-Reported Satiety Duration
Time Frame: Baseline, Week 2, Week 4, and Week 6
|
Change from Baseline in self-reported satiety duration as assessed via self-report questionnaire |
Baseline, Week 2, Week 4, and Week 6
|
|
Change in Self-Reported Food Craving Score
Time Frame: Baseline, Week 2, Week 4, and Week 6
|
Change from Baseline in self-reported food craving scores as assessed via the Food Cravings Questionnaire-Trait Reduced (FCQ-T-reduced) |
Baseline, Week 2, Week 4, and Week 6
|
|
Change in Self-Reported Skin Health Score
Time Frame: Baseline, Week 2, Week 4, and Week 6
|
Change from Baseline in self-reported skin health scores as assessed via self-report questionnaire |
Baseline, Week 2, Week 4, and Week 6
|
|
Change in Self-Reported Hair Health Score
Time Frame: Baseline, Week 2, Week 4, and Week 6
|
Change from Baseline in self-reported hair health scores as assessed via self-report questionnaire |
Baseline, Week 2, Week 4, and Week 6
|
|
Change in Self-Reported Nail Health Score
Time Frame: Baseline, Week 2, Week 4, and Week 6
|
Change from Baseline in self-reported nail health scores as assessed via self-report questionnaire |
Baseline, Week 2, Week 4, and Week 6
|
|
Change in Self-Reported Gut Comfort and Digestive Symptom Score
Time Frame: Baseline, Week 2, Week 4, and Week 6
|
Change from Baseline in self-reported gut comfort and digestive symptom scores as assessed via self-report questionnaire |
Baseline, Week 2, Week 4, and Week 6
|
|
Participant-Reported Product Satisfaction
Time Frame: Week 6
|
Participant-reported product satisfaction, acceptability, and tolerability as assessed via product satisfaction questionnaire |
Week 6
|
|
Participant-Reported Product Tolerability
Time Frame: Week 6
|
Participant-reported tolerability of the study product as assessed via product satisfaction questionnaire |
Week 6
|
|
Participant-Reported Overall Product Experience
Time Frame: Week 6
|
Participant-reported overall experience with the study product as assessed via product satisfaction questionnaire |
Week 6
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Study record dates
Study Major Dates
Study Start (Estimated)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- THECO-22384
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.